Revision history of "HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group." (Q44922022)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 May 2022

6 December 2021

5 December 2021

15 April 2021

18 April 2019

29 March 2019

  • curprev 23:3523:35, 29 March 2019Emijrpbot talk contribs 38,122 bytes +4,822 Updated Item: BOT - Adding descriptions (57 languages): ar, ast, bg, bn, ca, cs, da, de, el, eo, es, et, fa, fi, fr, gl, he, hu, hy, it, ja, ka, ko, lt, nan, nb, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cyrl, th, tl, tr, ur, vi, wuu, yue, zh, zh-cn, zh-hans, zh-hant, zh-hk, zh-mo, zh-my, zh-sg, zh-tw undo (restore)

16 November 2018

11 October 2018

22 June 2018

7 December 2017